Speaker illustration

Doctor Giuseppe Armentaro

Magna Graecia University of Catanzaro, Catanzaro (Italy)

Member of:

European Society of Cardiology
Heart Failure Association

Giuseppe Armentaro born in Saronno (VA),Lombardia, Italy in 26/05/1991. He obtained his master's degree from the School of Medicine, University of Magnae Graecia of Catanzaro (Calabria, Italy) in 26/07/2017, and obtained his abilitation to clinical practice in 05/03/2018. He is currently a Resident in Geriatric Unit of Mater Domini Hospital- University of Magnae Graecia in Catanzaro under the supervision of Prof. Angela Sciacqua. Area of interest: Heart Failure, Arterial hypertension, Atrial fibrillation, type 2 diabetes mellitus, COPD.

Short and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Cardiovascular Disease in the Elderly

Session: Heart disease in the elderly: treatment and outcomes

Thumbnail

Effect of semaglutide on global longitudinal strain and global myocardial work efficiency in patients with uncontrolled type 2 diabetes mellitus and obesity.

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Diabetes and the heart (3)

Thumbnail

Short term effect of sodium glucose cotransporter 2 inhibitors and sacubitril/valsartan on comprehensive geriatric assessment and oxidative stress in elderly with chronic heart failure (from MAGIC-HF)

Event: ESC Congress 2023

Topic: Comorbidities

Session: Comorbidities and heart failure: cause and effect

Thumbnail

Effects of sacubitril-valsartan on clinical, echocardiographic and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Neprilysin inhibition: news and nuggets

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb